Lou T - Search Results

1

Evening versus morning dosing regimen drug therapy for chronic kidney disease patients with hypertension in blood pressure patterns: a systematic review and meta-analysis.

Wang C, Ye Y, Liu C, Zhou Y, Lv L, Cheng C, Li S, Lou T, Liu X. Wang C, et al. Among authors: lou t. Intern Med J. 2017 Aug;47(8):900-906. doi: 10.1111/imj.13490. Intern Med J. 2017. PMID: 28544243 Review.

2

[Comparison of serum leptin clearance with different blood purification].

Lou TQ, You YP, Chen ZJ, Shi CG, Liu X, Tang H. Lou TQ, et al. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2003 Dec;15(12):742-4. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2003. PMID: 14659060 Chinese.

3

Randomised controlled trial of leflunomide in the treatment of immunoglobulin A nephropathy.

Lou T, Wang C, Chen Z, Shi C, Tang H, Liu X, Yin P, Yu X. Lou T, et al. Nephrology (Carlton). 2006 Apr;11(2):113-6. doi: 10.1111/j.1440-1797.2006.00547.x. Nephrology (Carlton). 2006. PMID: 16669971 Clinical Trial.

4

[Clinical control study of dialysates with different concentrations of calcium on blood pressure in patients under hemodialysis for prolonged period].

Wang C, Lou TQ, Chen ZJ, Tang H, Shi CG, Yu XQ, Yin PD. Wang C, et al. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2007 Apr;19(4):236-8. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2007. PMID: 17448281 Chinese.

5

Serum IgA1 from IgA nephropathy patients induces apoptosis in podocytes through direct and indirect pathways.

Wang C, Peng H, Tang H, Liu X, Chen Z, Lou T, Yu X. Wang C, et al. Among authors: lou t. Clin Invest Med. 2007;30(6):E240-9. doi: 10.25011/cim.v30i6.2952. Clin Invest Med. 2007. PMID: 18053391

6

[Study on protective effects and its mechanism of leflunomide on renal tissue in rat IgA nephropathy model].

Tang Y, Lou TQ, Wang C, Peng H, Liu X, Tang H. Tang Y, et al. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2008 May;20(5):283-5. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2008. PMID: 18471359 Chinese.

7

Effect of aggregated immunoglobulin A1 from immunoglobulin A nephropathy patients on nephrin expression in podocytes.

Wang C, Ye Z, Peng H, Tang H, Liu X, Chen Z, Yu X, Lou T. Wang C, et al. Among authors: lou t. Nephrology (Carlton). 2009 Apr;14(2):213-8. doi: 10.1111/j.1440-1797.2008.01025.x. Nephrology (Carlton). 2009. PMID: 19019169

8

Serum IgA1 from patients with IgA nephropathy up-regulates integrin-linked kinase synthesis and inhibits adhesive capacity in podocytes through indirect pathways.

Ye ZC, Wang C, Tang Y, Liu X, Peng H, Zhang H, Lou TQ. Ye ZC, et al. Clin Invest Med. 2009 Feb 1;32(1):E20-7. doi: 10.25011/cim.v32i1.5083. Clin Invest Med. 2009. PMID: 19178875

9

Mesangial medium with IgA1 from IgA nephropathy inhibits nephrin expression in mouse podocytes.

Wang C, Liu X, Ye Z, Zhang J, Tang H, Chen Z, Zhang H, Lou T. Wang C, et al. Among authors: lou t. Eur J Clin Invest. 2009 Jul;39(7):561-7. doi: 10.1111/j.1365-2362.2009.02135.x. Epub 2009 Apr 24. Eur J Clin Invest. 2009. PMID: 19397686

10

Mesangial cells stimulated by immunoglobin A1 from IgA nephropathy upregulates transforming growth factor-beta1 synthesis in podocytes via renin-angiotensin system activation.

Wang C, Liu X, Peng H, Tang Y, Tang H, Chen Z, Lou T, Zhang H. Wang C, et al. Among authors: lou t. Arch Med Res. 2010 May;41(4):255-60. doi: 10.1016/j.arcmed.2010.05.003. Arch Med Res. 2010. PMID: 20637368

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

400 results

Search Page

Filters